Full-fledged operation of control tower for vaccine development in various fields Top priority is to export the vaccines to countries with low vaccine availability, as well as Korea

IL-YANG Pharmaceutical’s vaccine plant is built on a land covering an area of 89,256㎡ with the gross floor area of 13,361㎡ and has established the vaccine manufacturing line with an annual production capacity of 60 million doses. IL-YANG Pharmaceutical operates the vaccine bulk production plant, which is not many worldwide, and the vaccine

manufacturing plant equipped with basic vaccine vaccine bulk production facilities, etc., focusing on the production of vaccine from high quality and high efficiency fertile eggs incubated within GMP facilities in advance to ensure high safety.

Equipped with the latest production facilities and systems, IL-YANG Pharmaceutical’s vaccine plant manufactures the excellent vaccine bulk, playing a pivotal role in ensuring undisrupted supply of excellent vaccines nationwide and exporting the vaccines to foreign countries where the vaccine availability and coverage remain low.

IL-YANG Pharmaceutical is carrying on vaccine business without any error by fully leveraging on its well-recognized new drug development capability and R&D technology, and will take the lead in turning Korea to the powerhouse of preventive medicine, as well as help promote the advancement of domestic pharmaceutical industry, by operating the control tower for vaccine development in various fields. As a leader in R&D and technology for medicine, IL-YANG Pharmaceutical has mapped out perfect plans and made preparations for technology and information-intensive vaccine business and is pouring all energy for vaccine development to help usher in new future. IL-YANG Pharmaceutical will make utmost effort to evolve into a global provider of vaccines, helping promote the health of the public and humanity, and create better future.